Inflazyme Pharmaceuticals (Research & Development assets) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Inflazyme Pharmaceuticals (Research & Development assets) General Information
Description
Portfolio of biotechnological research and development programs and assets. The assets included programs on the LSAIDs, the PDE inhibitors and the Protein Therapeutics Technology.
Contact Information
Corporate Office
- Montreal, Quebec
- Canada
Corporate Office
- Montreal, Quebec
- Canada
Inflazyme Pharmaceuticals (Research & Development assets) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Inflazyme Pharmaceuticals (Research & Development assets) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Inflazyme Pharmaceuticals (Research & Development assets) FAQs
-
Where is Inflazyme Pharmaceuticals (Research & Development assets) headquartered?
Inflazyme Pharmaceuticals (Research & Development assets) is headquartered in Montreal, Canada.
-
What industry is Inflazyme Pharmaceuticals (Research & Development assets) in?
Inflazyme Pharmaceuticals (Research & Development assets)’s primary industry is Buildings and Property.
-
Is Inflazyme Pharmaceuticals (Research & Development assets) a private or public company?
Inflazyme Pharmaceuticals (Research & Development assets) is a Private company.
-
What is the current valuation of Inflazyme Pharmaceuticals (Research & Development assets)?
The current valuation of Inflazyme Pharmaceuticals (Research & Development assets) is .
-
What is Inflazyme Pharmaceuticals (Research & Development assets)’s current revenue?
The current revenue for Inflazyme Pharmaceuticals (Research & Development assets) is .
-
Who are Inflazyme Pharmaceuticals (Research & Development assets)’s investors?
EACOM Timber has invested in Inflazyme Pharmaceuticals (Research & Development assets).
-
When was Inflazyme Pharmaceuticals (Research & Development assets) acquired?
Inflazyme Pharmaceuticals (Research & Development assets) was acquired on 19-Nov-2007.
-
Who acquired Inflazyme Pharmaceuticals (Research & Development assets)?
Inflazyme Pharmaceuticals (Research & Development assets) was acquired by Biolipox.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process